Myriad Genetics, Inc.
/K I L L K I L L K I L L — Myriad Genetics, Inc.
DGAP-News: Myriad Genetics, Inc. / 07.04.2014 / 16:53 --------------------------------------------------------------------- SALT LAKE CITY, 2014-04-07 16:53 CEST (GLOBE NEWSWIRE) -- Please be advised that journalists and other readers should disregard the news release, 'Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)' issued April 7, 2014 by Myriad Genetics, Inc., over GlobeNewswire. News Source: NASDAQ OMX End of Corporate News --------------------------------------------------------------------- 07.04.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Myriad Genetics, Inc. United States ISIN: US62855J1043 End of News DGAP News-Service --------------------------------------------------------------------- 262025 07.04.2014
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found